Rheumatoid arthritis patients taking Humira or Remicade face triple the risk of developing several kinds of cancer and double the risk of getting serious infections, a study led by the Mayo Clinic found. (MSNBC)

April 07, 2005

"A top-selling cancer drug co-developed by Switzerland's Roche also helps patients with a hard-to-treat form of rheumatoid arthritis, data showed on Wednesday, opening the door to a potential major new market."

Posted by news editor | Filed under: Rheumatoid Arthritis

March 22, 2005

"Multiple sclerosis patients are being given hope following trials of a drug made from goats' blood, doctors say ... The drug, called Aimspro, is not licensed in any country yet, but makers Daval International said they hoped to be granted one within a year."

Posted by news editor | Filed under: Multiple Sclerosis

March 02, 2005

Tysabri, a drug approved by the FDA three months ago for multiple sclerosis, has been withdrawn from the market after cases of death were reported.

Posted by news editor | Filed under: Multiple Sclerosis

September 30, 2004

"The Food and Drug Administration (FDA) Thursday acknowledged the voluntary withdrawal from the market of Vioxx (chemical name rofecoxib), a non-steroidal anti-inflammatory drug (NSAID) manufactured by Merck & Co."

"India's traditional diabetes remedy from its native curry-leaf tree really does work, and could potentially be the making of a multi-billion dollar alternative drug, a landmark British pharmaceutical conference heard on Wednesday."

Posted by news editor | Filed under: Medication